Bodycote PLC Stock Rating Reaffirmed by Credit Suisse (BOY)
Bodycote PLC (LON:BOY)‘s stock had its “outperform” rating reiterated by research analysts at Credit Suisse in a report released on Friday. They currently have a GBX 810 ($13.63) target price on the stock. Credit Suisse’s target price would indicate a potential upside of 20.36% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Panmure Gordon reiterated a “buy” rating on shares of Bodycote PLC in a research note on Friday, August 1st. They now have a GBX 2,034 ($34.23) price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Bodycote PLC in a research note on Friday, August 1st. They now have a GBX 825 ($13.88) price target on the stock. Finally, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Bodycote PLC in a research note on Thursday, July 31st. They now have a GBX 825 ($13.88) price target on the stock. Two analysts have rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of GBX 889.17 ($14.96).
Shares of Bodycote PLC (LON:BOY) opened at 664.50 on Friday. Bodycote PLC has a one year low of GBX 595.00 and a one year high of GBX 832.00. The stock’s 50-day moving average is GBX 687.3 and its 200-day moving average is GBX 725.0. The company’s market cap is £1.264 billion.
The company also recently announced a dividend, which is scheduled for Friday, November 7th. Investors of record on Wednesday, October 1st will be paid a dividend of GBX 4.60 ($0.08) per share. This represents a dividend yield of 0.66%. The ex-dividend date is Wednesday, October 1st.
Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.